Dr. Maria Elena Bottazzi is the distinguished speaker for The Wistar Institute Women & Science Program on April 27, 2023 at 5:00 – 6:00 p.m. Dr. Bottazzi is Associate Dean of the National School of Tropical Medicine, Professor of Pediatric…
An $80,000 grant for The Wistar Institute’s HIV-1 Patient Partnership for Basic Research program from the Robert I. Jacobs Fund of Philadelphia Foundation not only advances ongoing basic research into ways to prevent, treat and ultimately cure HIV…
On Friday, February 24, 2023, more than 175 postdoctoral, graduate, and undergraduate students from around Philadelphia came together for the very first Wistar Institute Trainee Research Symposium. The Symposium was developed and run by leaders of W…
Dr. Luis J. Montaner and lab find common, persistent symptoms for long-haulers by reviewing a multitude of research studies. An international team of researchers led by The Wistar Institute’s lead scientist on HIV-cure research has published a revie…
Some cancers are linked to viral infections. Studying viruses found in tumor cells can reveal important information in the development of more effective cancer treatments. Wistar researchers developed a tool to study the expression of cancer-related…
MEDIA ADVISORY WHAT:The Wistar Institute and Stowers Institute for Medical Research in Kansas City Announces Friendly Super Bowl Wager between the Two Biomedical Research Institutes The Wistar Institute have made a friendly wager with Stowers Instit…
PHILADELPHIA — (FEBRUARY, 6, 2023) — In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Progra…
What clues can a cell’s death reveal for immunotherapies for treating cancer and other diseases? Wistar scientists Dr. Yulia Nefedova, associate professor in the Immunology, Microenvironment & Metastasis Program in the Ellen and Ronald Caplan Ca…
The annual award supports early career investigators and their work advancing in the immunology, vaccine, and immunotherapy space. Noam Auslander, Ph.D., Assistant Professor in the Molecular & Cellular Oncogenesis Program of the Ellen and R…
PHILADELPHIA — (Jan. 24, 2023) — The Wistar Institute, which has recently launched a $75 million programmatic campaign investing in biomedical advances, announces the appointment of Michael Criscuolo as Vice President of Development. “We are delight…
